Delivery Order SPE2DB22D1017-SPE2DB25FG9EV
- Not listed
- AmerisourceBergen Drug Corp received a $1,194.93 firm fixed-price delivery order from the Defense Logistics Agency (DLA) on March 18, 2025, for Diclofenac-Misoprostol 75-0.2 mg tablets (60-count supply). The contract, which is neither set-aside nor restricted, has an ultimate completion date of March 19, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $5,219.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Diclofenac-Misoprostol 75-0.2 mg tablets (60-count) on May 30, 2025, with a completion date of June 2, 2025. This non-set-aside contract represents a routine pharmaceutical supply delivery under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The delivery will be fulfilled from the contractor's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a $1,272.44 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Diclofenac-Misoprostol 50-0.2 mg tablets (60-count units) on July 31, 2025, with completion scheduled for August 1, 2025. This award was not designated as a set-aside contract and represents a routine pharmaceutical procurement through the federal medical supply chain. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred two dollars and ninety-seven cents to Amerisourcebergen Drug Corporation for fifty milligram diclofenac misoprostol tablets. Amerisourcebergen Drug Corporation will deliver sixty tablets to a location in Conshohocken, Pennsylvania by August third, twenty twenty-three as the prime contractor. The Defense Logistics Agency procures medical supplies and pharmaceuticals to support the United States Department...
- The Defense Logistics Agency awarded a $580 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Diclofenac-Misoprost 75-0.2 mg 60s tablets. The place of performance is Conshohocken, Pennsylvania. The order runs from August 3, 2023 through August 4, 2023 to fulfill a requirement for the pharmaceutical product. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the tablets to the Defense Logistics Agency, the Department of Defense agency responsible...
- The Defense Logistics Agency Troop Support Medical awarded a $330 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Diclofenac-Misoprost 75-0.2 mg 60s tablets. The place of performance is Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is July 19-20, 2023. No set aside designation or subcontractors are indicated. The Defense Logistics Agency supports Department of Defense health care programs by procuring pharmaceuticals and...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,050.58 firm fixed-price delivery order is for the supply of 4,559,130,960 tablets of diclofenac sodium delayed-release 75 mg. The contract has a completion date of November 18, 2022 and was awarded on November 17, 2022. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency awarded a $702.72 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4561344309 DICLOFENAC-MISOPROST 75-0.2 MG 60S. The place of performance will be Amerisourcebergen's Conshohocken, Pennsylvania facility. The period of performance is one day, from June 26, 2023 through June 27, 2023. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, this order for non-prescription pain relievers is...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, with a ceiling value of $1,085.05, is for the delivery of diclofenac-misoprost 75-0.2 mg medication in 60-count packages. The contract is a firm fixed price Delivery Order, with an ultimate completion date of December 9, 2021. There is no set-aside designation associated with this award. Amerisourcebergen Drug Corp is a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,700.71, is a delivery order contract for the supply of DICLOFENAC-MISOPROST 75-0.2 MG 60S pharmaceutical products. The contract has a firm fixed price pricing type and an ultimate completion date of March 19, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB25FG9EVDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,391.14 for Diclofenac-Misoprostol 75-0.2 mg tablets (60 count) on August 7, 2025, with an ultimate completion date of August 8, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is fulfilled from the vendor's Conshohocken, Pennsylvania facility. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime vendor agreement running through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal medical procurement vendor for military and veteran healthcare systems. As a prime contractor under the DLA's pharmaceutical supply chain, the company delivers an extensive portfolio of medications and medical commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This delivery order for the pain management and anti-inflammatory medication reflects the company's ongoing role in fulfilling federal pharmaceutical needs through the DLA's strategic procurement framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/7/25 |